Login

Tag: drug industry

drug industry

Washington Focus

Kamp: Buckle Up for a Bumpy Ride with Trump

Kamp: Buckle Up for a Bumpy Ride with Trump

Coalition Commentary by Executive Director John Kamp Feb. 6, 2017 — Fasten your seatbelts and put your tray tables in their upright and locked position as you watch the Trump administration land on our industry. At a recent White House meeting with PhRMA and industry CEOs,  Trump made sure the cameras were rolling as he […]

Read more

Changing of the Guard at PhRMA

April 20, 2015 – The Pharmaceutical Research and Manufacturers of America (PhRMA) last week announced changes to its board – including the appointment of Merck’s Kenneth C. Frazier as chairman of the PhRMA Board – as well as the upcoming retirement of PhRMA President and CEO John J. Castellani. “PhRMA is pleased to welcome Ken […]

Read more

Categories

Recent Posts

Tags

ACA ad tax CDER chc CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy data privacy legislation DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media FTC gifts to physicians HHS Jim Potter John Kamp Jon Bigelow kamp Kate Rawson legislation litigation off-label off-label communication OPDP OPDP enforcement PhRMA regulation rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines